Prothena (NASDAQ:PRTA) PT Lowered to $81.00

Prothena (NASDAQ:PRTA – Get Free Report) had its target price lowered by JMP Securities from $83.00 to $81.00 in a research note issued on Friday, Benzinga reports. The brokerage presently has a “market outperform” rating on the biotechnology company’s stock. JMP Securities’ price target indicates a potential upside of 115.71% from the stock’s previous close. […]

Related Keywords

Texas ,United States ,China ,Hideki Garren ,Karinl Walker ,Cantor Fitzgerald ,Td Asset Management Inc ,Jennison Associates ,Prothena Corporation ,China Universal Asset Management Co ,Allspring Global Investments Holdings ,Get Free Report ,Retirement System ,Universal Asset Management ,Global Investments Holdings ,Management Inc ,Prothena Daily ,Prothena ,Nasdaq Prta ,Pprta ,Medical ,Lower Price Target ,Jmp Securities ,